Teratogenic effects of vigabatrin in TO mouse fetuses

Teratology

Volumn 55, Issue 3, 1997, Pages 165-176

  Abdulrazzaq, Yousef M ^a   Bastaki, Salim M A ^a   Padmanabhan, R ^a  

^a UNITED ARAB EMIRATES UNIVERSITY   (United Arab Emirates)

Author keywords

[No Author keywords available]

Indexed keywords

ALCIAN BLUE; ALIZARIN RED S; ANTICONVULSIVE AGENT; VIGABATRIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN DEVELOPMENT; CLEFT PALATE; CONTROLLED STUDY; DEVELOPMENTAL GENETICS; EMBRYO; EMBRYO PATTERN FORMATION; FACIAL BONE; FEMALE; FETUS; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAUTERINE GROWTH RETARDATION; LIMB DEFECT; MANDIBLE HYPOPLASIA; MAXILLA HYPOPLASIA; MOUSE; NEURAL TUBE DEFECT; NONHUMAN; PALATE MALFORMATION; PRIORITY JOURNAL; RIB; RIB MALFORMATION; TERATOGENESIS; UMBILICAL HERNIA; VERTEBRA MALFORMATION;

ABNORMALITIES, DRUG-INDUCED; ANIMALS; ANTICONVULSANTS; BONE AND BONES; EMBRYO LOSS; FETAL GROWTH RETARDATION; FETAL RESORPTION; GAMMA-AMINOBUTYRIC ACID; LIMB DEFORMITIES, CONGENITAL; MICE; NEURAL TUBE DEFECTS; RIBS; SKULL; SPINE; STERNUM; TERATOGENS; VIGABATRIN;

ANIMALIA;

EID: 0030788657     PISSN: 00403709     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9926(199703)55:3<165::AID-TERA1>3.0.CO;2-1     Document Type: Article

References (57)

1. Annegers, J.F., W.A. Hauser, L.R. Elveback, V.E. Anderson, and L.T. Kuriand (1978) Congenital malformations and seizure disorders in the offspring of parents with epilepsy. Int. J. Epidemiol., 7:241-247.
2. Beyer, P.E., and N. Chernoff (1986) The induction of supernumerary ribs in rodents: Role of maternal stress. Teratogen. Carcinogen. Mutagen., 6:416-429.
3. Brown, N.A., and C.W. Colhoun (1984) Valproic acid teratogenesis. I. In vivo/in vitro comparisons and effects on somite morphogenesis. Teratology, 29:20-21A.
4. Buehler, B.A., D. Delimont, M. Van Waer, and R.H. Finnel (1990) Prenatal prediction of risk of fetal hydantoin syndrome. N. Engl. J. Med., 322:1567-1572.
5. Challier, J.C., E. Rey, T. Bintein, and G. Olive (1992) Passage of S(+) and R(-) gamma-vinyl-GABA across the human isolated perfused placenta. Br. J. Clin. Pharmacol., 34:139-143.
6. Dalessio, D.J. (1985) Medical intelligence: Current concepts, seizure disorders and pregnancy. N. Engl. J. Med., 312:559-563.
7. Editorial (1991) Teratogenesis with carbamazepine. Lancet, 337:1316-1317.
8. Elzey, F.F. (1987) Introductory Statistics: A Microcomputer Approach. Adopted for IBM-PC by R.D. Cloward. Brooks/Cole Publishing Co., Monterey, CA.
9. Finnel, R.H. (1991) Genetic differences in susceptibility to anticonvulsant drug-induced developmental defects. Pharmacol. Toxicol., 69: 223-227.
10. Gailey, E., M.L. Granstrom, V. Hilesmaa, and A. Bardy (1988) Minor anomalies in offspring of epileptic mothers. J. Pediatr., 112:520-529.
11. Grant, S.M., and R.C. Heel (1991) Vigabatrin: A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in epilepsy and disorders of motor control. Drug, 41:889-926.
12. Hanson, J.W., H.H. Ardinger, J. Di Liberti, et al. (1984) Effects of valproic acid on the fetus. Pediatr. Res., 18:306A.
13. Inouye, M. (1976) Differential staining of cartilage and bone in fetal mouse skeleton by alcian blue and alizarin red-S. Congenital Anomalies, 16:171-173.
14. Janz, D. (1982) On major malformations and minor anomalies in the offspring of parents with epilepsy. In: Epilepsy, Pregnancy and the Child. D. Janz, L. Bossi, M. Dam, H. Helge, A. Richens, and S. Schmidt, eds. Raven Press, New York, pp. 221-222.
15. Jegalian, B.G., and E.M. De Robertis (1992) Homeotic transformation in the mouse induced by overexpression of a human Hox 3.3 transgene. Cell, 71:901-910.
16. Kalter, H., and J. Warkany (1983) Congenital malformations. N. Engl. J. Med., 308:491-497.
17. Kaneko, S., K. Otani, Y. Fukushima, et al. (1988) Teratogenicity of antiepileptic drugs: Analysis of possible risk factors. Epilepsia, 29:459-467.
18. Kao, J., N.A. Brown, B. Schmids, E.H. Goulding, and S. Fabro (1981) Teratogenicity of valproic acid in vivo and in vitro investigations. Teratogen. Carcinogen. Mutagen., 1:367-382.
19. Kelly, T.E. (1984) Teratogenicity of anticonvulsant drugs. I. Review of the literature. Am. J. Med. Genet., 19:413-434.
20. Kessel, M. (1992) Respecification of vertebral identities by retinoic acid. Development, 115:4487-4501.
21. Kessel, M., and P. Gruss (1991) Homeotic transformations of murine vertebrae and concomitant alterations of Hox codes induced by retinoic acid. Cell, 67:89-104.
22. Khoury, M.J., J.F. Cordero, J. Mulinare, and J.M. Opitz (1989) Selected midline associations: A population study. Pediatrics, 84:266-272.
23. Khoury, M.J., L.M. James, W.D. Flanders, and J.D. Erickson (1992) Interpretation of recurring weak associations obtained from epidemiological studies of suspected human teratogens. Teratology, 46:69-77.
24. Koch, S., G. Loesche, E. Jager Roman, et al. (1992) Major birth malformations and antiepileptic drugs. Neurology, 42(Suppl 5):83-88.
25. Kramer, G. (1992) Vigabatrin: Wisksmkeit und Vertrag lichkeit bei epilepsein in Erwachsenenalter. Akt. Neurol., 19:828-840.
26. Lammer, E.J., L.E. Sever, and G.P. Oakley, Jr (1987) Teratogen update: Valproic acid. Teratology, 35:465-473.
27. Landa, A.I., and A.O. Donoso (1987) Blockade of pro-oestrus LH surge and ovulation by GABA increase in the rat locus coeruleus. Acta Endocrinol. Copenh., 115:490-496.
28. Lindhout, D., and J.G.C. Omtzigt (1994) Teratogenic effects of antiepileptic drugs: Implications for the management of epilepsy in women of childbearing age. Epilepsia, 35(Suppl 4):S19-S28.
29. Lindhout, D., H. Meinardi, J.W.A. Meijer, et al. (1992) Antiepileptic drugs and teratogenesis in two consecutive cohorts: Changes in prescription policy, paralleled by changes in pattern of malformations. Neurology, 42(Suppl):94-110.
30. Lindhout, D., J.E. Rene, and H. Meinardi (1984) Teratogenicity of antiepileptic drug combinations with special emphasis on oxidation (of carbamazepine). Epilepsia, 25:77-83.
31. Martinez-Frias, M.L. (1990) Clinical manifestation of prenatal exposure to valproic acid using case reports and epidemiologic information. Am. J. Med. Genet., 37:277-282.
32. Meadow, R. (1991) Anticonvulsants in pregnancy. Arch. Dis. Child., 66:62-65.
33. Meadow, S.R. (1968) Anticonvulsant drugs and congenital abnormalities. Lancet, 2:1296.
34. Miyagawa, A., T. Hara, T. Okura, et al. (1971) Toxicity testing of sodium dipropylacetate - Acute toxicity, subacute toxicity and teratogenicity testing. Clin. Rep., 5:41-65.
35. Montouris, G.D., G.M. Fenichel, and W. McLain (1979) The pregnant epileptic. Arch. Neurol., 36:601-603.
36. Nakane, Y., and S. Kaneko (1992) Congenital anomalies in the offspring of epileptic mothers. Congenital Anomalies, 32:309-321.
37. Nakane, Y., T. Okuma, R. Takashi, et al. (1980) Multi-institutional study on the teratogenicity and fetal toxicity of antiepileptic drugs: A report of collaborative study group in Japan. Epilepsia, 21:663-680.
38. Ong, L.I., J.L. Schardein, J.A. Petrere, R. Sakowski, H. Jordan, R. Humphrey, J.E. Fitzgerald, and F.A. Iglesia (1983) Teratogenesis of calcium valproate in rats. Fundam. Appl. Toxicol., 3:121-126.
39. Padmanabhan, R., and I. Ahmed (1996) Sodium valproate augments spontaneous neural tube defects and axial skeletal malformations in TO mouse fetuses. Reprod. Toxicol. 10:345-363.
40. Padmanabhan, R., and M.S. Hameed (1994) Exencephaly and axial skeletal malformations induced by maternal administration of sodium valproate in the MF1 mouse. J. Craniofac. Genet. Dev. Biol., 14:192-205.
41. Padmanabhan, R., I.A. Wasfi, and M.B.L. Craigmyle (1994) Effect of pre-treatment with aspirin on alcohol-induced neural tube defects in the TO mouse fetuses. Drug Alcohol Depend., 36:175-186.
42. Petrere, J.A., J.A. Anderson, R. Sakowski, J.I.E. Fitzgerald, and F.A. De La Iglesia (1986) Teratogenesis of calcium valproate in rabbit. Teratology, 34:263-269.
43. Qureshi, G.A., I. Badnar, B.G. Forsberg, and P. Sodersten (1988) GABAinhibits sexual behavior in female rats. Neuroscience, 27:169-174.
44. Robert, E., and P. Guibaud (1982) Maternal valproic acid and congenital neural tube defects. Lancet, 2:937.
45. Robert, E., and F. Rosa (1983) Valproate and birth defects. Lancet, 2:1142.
46. Russell, L.B. (1979) Sensitivity patterns for the induction of homeotic shifts in a favourable strain of mice. Teratology, 20:115-126.
47. Shapiro, S., S.C. Hartz, V. Siskind, A.A. Mitchell, D. Slone, L. Rosenberg, P.R. Monson, and O.P. Heinonen (1976) Anticonvulsants and prenatal epilepsy in the development of birth defects. Lancet, 1:272-275.
48. Speidel, B.D., and S.R. Meadow (1972) Maternal epilepsy and abnormalities of the fetus and the newborn. Lancet, 2:839-843.
49. Sterz, H., and H. Lehmann (1985) A critical comparison of the freehand razor blade dissection method according to Wilson with an in situ sectioning method for rat fetuses. Teratogen. Carcinogen. Mutagen., 5:347-354.
50. Strickler, S.M., M.A. Miller, E. Andermant, L.V. Dansky, M.H. Seni, and S.P. Spielberg (1985) Genetic predisposition to phenytoin induced birth defects. Lancet, 5:746-749.
51. Svigos, J.M. (1984) Epilepsy and pregnancy. Aust. N.Z. J. Obstet. Gynaecol., 24:182-185.
52. Tein, I., and D.L. MacGregor (1985) Possible valproate teratogenicity. Arch. Neurol., 42:291-293.
53. Thomson, A.H., and M.J. Brodie (1992) Pharmacokinetic optimization of anticonvulsant therapy. Clin. Pharmacokinet., 23:216-230.
54. Van Allen, M.I. (1981) Fetal vascular disruptions: Mechanisms and some resulting birth defects. Pediatr. Ann., 10:219-233.
55. Wilson, J.G. (1964) Teratogenic interaction of chemical agents in the rat. J. Pharmacol. Exp. Ther., 144:429-436.
56. Wilson, J.G. (1973) Environment and Birth Defects. Academic Press, New York.
57. Yerby, M.S. (1991) Pregnancy and epilepsy. Epilepsia, 32(Suppl 6):51-59.